Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
Enveric Biosciences, Inc.
Last earnings -1.7% on 2026-05-15
Conservative balance sheet (liabilities/equity 0.96x); but revenue declined -7.2% YoY.
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
Enveric Biosciences, Inc. shows $39.9M in FY2019 revenue (-7.2% YoY), a -22.0% net margin, and -210.0% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
Sources: SEC EDGAR (CIK 0000890821, latest 10-Q filed 2026-05-15) · EODHD · rules-based read · as of 6/18/2026, 1:05:23 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$64.6M | -$27.4M | -$16.4M | -$9.63M | -$8.77M |
| Net income | -$49.0M | -$18.5M | -$17.3M | -$9.57M | -$8.77M |
| Diluted EPS | — | -$13.00 | -$121.29 | -$228.48 | -$36.24 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median
| 2026-06-01 | Coveney Kevin Michael Chief Financial Officer | Award | 133K | |
| 2026-06-01 | Tucker Joseph Edward Chief Executive Officer | Award | 201K | |
| 2026-06-01 | PASQUALONE FRANK Director | Award | 18.5K | |
| 2026-06-01 | WEBB MICHAEL D Director | Award | 18.5K | |
| 2026-06-01 | Schabacker Marcus Director | Award | 18.5K | |
| 2026-06-01 | Kegler George A. Director | Award | 18.5K | |
| 2026-06-01 | DeWitt Sheila Director | Award | 18.5K | |
| 2026-06-01 | Facchini Peter J. Chief Innovation Officer | Award | 25.0K |